Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
82.76
+8.71 (11.76%)
At close: Sep 2, 2026, 4:00 PM EDT
82.26
-0.50 (-0.60%)
Pre-market: Sep 3, 2026, 5:48 AM EDT
Tarsus Pharmaceuticals Market Cap
Tarsus Pharmaceuticals has a market cap or net worth of $3.63 billion as of September 2, 2026. Its market cap has increased by 46.86% in one year.
Market Cap
3.63B
Enterprise Value
3.27B
1-Year Change
46.86%
Ranking
Category
Stock Price
$82.76
ChartMarket Cap Chart
Since the IPO on October 16, 2020, Tarsus Pharmaceuticals's market cap has increased from $308.14M to $3.63B, an increase of 1,078.59%. That is a compound annual growth rate of 52.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 3.63B | 4.49% |
| Dec 31, 2025 | 3.48B | 64.21% |
| Dec 31, 2024 | 2.12B | 215.74% |
| Dec 29, 2023 | 670.37M | 71.44% |
| Dec 30, 2022 | 391.01M | -15.95% |
| Dec 31, 2021 | 465.23M | -44.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Relay Therapeutics | 4.06B |
| Viking Therapeutics | 3.91B |
| Iovance Biotherapeutics | 3.90B |
| IDEAYA Biosciences | 3.88B |
| Telix Pharmaceuticals | 3.82B |
| Arcus Biosciences | 3.80B |
| Tango Therapeutics | 3.76B |
| AbCellera Biologics | 3.68B |